Works by van de Donk, Niels W.C.J.

Results: 16

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02134

By:

van de Donk, Niels W.C.J.;
Usmani, Saad Z.

Publication type:

Article

Acute and chronic renal artery stenosis.

Published in:

European Heart Journal, 2010, v. 31, n. 1, p. 14, doi. 10.1093/eurheartj/ehp455

By:

van de Donk, Niels W.C.J.;
Kooij, Nina;
Visseren, Frank L.J.

Publication type:

Article

Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 665, doi. 10.1016/j.clml.2024.05.003

By:

Chari, Ajai;
Krishnan, Amrita;
Rasche, Leo;
Ye, Jing Christine;
Garfall, Alfred;
Popat, Rakesh;
Lipe, Brea;
Qin, Xiang;
Campagna, Michela;
Masterson, Tara;
Tomlinson, Chalmer;
Hilder, Brandi;
Tolbert, Jaszianne;
Renaud, Thomas;
Smit, M. Damiette;
Gray, Kathleen;
Kane, Colleen;
Heuck, Christoph;
Donk, Niels W.C.J. van de

Publication type:

Article

Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 350, doi. 10.1016/j.clml.2024.03.005

By:

Raje, Noopur S.;
Cohen, Adam D.;
Patel, Krina K.;
de Donk, Niels W.C.J. van;
Richter, Joshua;
San-Miguel, Jesus

Publication type:

Article

Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 413, doi. 10.1016/j.clml.2023.03.009

By:

Terpos, Evangelos;
Neri, Paola;
van de Donk, Niels W.C.J.;
D'Agostino, Mattia;
Parekh, Samir;
Jagannath, Sundar;
Ludwig, Heinz;
Avigan, David E.;
Dhodapkar, Madhav V.;
Raje, Noopur S.

Publication type:

Article

P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2

By:

Lonial, Sagar;
Berdeja, Jesus G.;
Dimopoulos, Meletios-Athanasios;
Jagannath, Sundar;
Knop, Stefan;
Hang Quach;
Rodríguez-Otero, Paula;
Richardson, Paul G.;
Sorrell, April;
Min Chen;
Kueenburg, Elisabeth;
Tuong Vi Nguyen;
Hong, Kevin;
Peluso, Teresa;
van de Donk, Niels W.C.J.

Publication type:

Article

P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S120, doi. 10.1016/S2152-2650(21)02282-5

By:

Einsele, Hermann;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, María-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Dong Geng;
Jakubowiak, Andrzej;
Cohen, Adam

Publication type:

Article

OAB-025: Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)×CD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S16, doi. 10.1016/S2152-2650(21)02099-1

By:

Donk, Niels W.C.J. van de;
Krishnan, Amrita;
Oriol, A;
Berdeja, Jesus G.;
Rodríguez-Otero, Paula;
Askari, Elham;
Mateos, María-Victoria;
Minnema, Monique C.;
Costa, Luciano;
Verona, Raluca;
Girgis, Suzette;
Prior, Thomas;
Hilder, Brandi;
Russell, Jeffery;
Goldberg, Jenna;
Chari, Ajai

Publication type:

Article

OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5

By:

Lonial, Sagar;
Richardson, Paul G.;
Popat, Rakesh;
Stadtmauer, Edward A.;
Larsen, Jeremy T.;
Oriol, A.;
Knop, Stefan;
Jagannath, Sundar;
Cook, Gordon;
Badros, Ashraf Z.;
Rodríguez-Otero, Paula;
Siegel, David S.;
Tuong Vi Nguyen;
Micco, Antonia Di;
Amin, Alpesh;
Min Chen;
Kueenburg, Elisabeth;
van de Donk, Niels W.C.J.

Publication type:

Article

OAB-008: Identification of high-risk Multiple Myeloma with a plasma cell Leukemia-like transcriptomic profile.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02082-6

By:

Bruinink, Davine Hofste op;
Kuiper, Rowan;
Duin, Mark van;
Cupedo, Tom;
Velden, Vincent H.J. van der;
Hoogenboezem, Remco;
Holt, Bronno van der;
Beverloo, H. Berna;
Valent, Erik T.;
Vermeulen, Michael;
Gay, Francesca;
Broijl, Annemiek;
Avet-Loiseau, Hervé;
Munshi, Nikhil C.;
Musto, Pellegrino;
Moreau, Philippe;
Zweegman, Sonja;
Donk, Niels W.C.J. van de;
Sonneveld, Pieter

Publication type:

Article

MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01945-5

By:

Jakubowiak, Andrzej;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, Maria-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Geng, Dong;
Einsele, Hermann;
Cohen, Adam

Publication type:

Article

Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01568-8

By:

Jakubowiak, Andrzej;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, Maria-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Geng, Dong;
Einsele, Hermann;
Cohen, Adam

Publication type:

Article

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment.

Published in:

2019

By:

Frerichs, Kristine A.;
Bosman, Patricia W.C.;
Nijhof, Inger S.;
Zweegman, Sonja;
van de Donk, Niels W.C.J.

Publication type:

journal article

Response to: Interference of daratumumab on the serum protein electrophoresis.

Published in:

Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 2, p. e29, doi. 10.1515/cclm-2016-1026

By:

McCudden, Christopher;
Axel, Amy E.;
Slaets, Dominique;
Dejoie, Thomas;
Clemens, Pamela;
Frans, Sandy;
Bald, Jaime;
Plesner, Torben;
Jacobs, Joannes F.M.;
van de Donk, Niels W.C.J.;
Moreau, Philippe;
Schecter, Jordan M.;
Ahmadi, Tahamtan;
Sasser, A. Kate

Publication type:

Article

Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy.

Published in:

2001

By:

Eurelings, Marijke;
Notermans, Nicolette C.;
Van de Donk, Niels W.C.J.;
Lokhorst, Henk M.;
Eurelings, M;
Notermans, N C;
Van de Donk, N W;
Lokhorst, H M

Publication type:

journal article

Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis.

Published in:

EJHaem, 2022, v. 3, n. 2, p. 565, doi. 10.1002/jha2.424

By:

Kwakernaak, Arjan J.;
Bernelot Moens, Sophie J.;
Hilhorst, Marc L.;
Florquin, Sandrine;
van de Donk, Niels W.C.J.;
Vos, Josephine M.I.

Publication type:

Article